Bank of America
DVAX

Bank of America’s Dynavax Technologies DVAX Stock Holding History

Bank of America’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-66,100
Closed -$638K – 7091
2017
Q2 		$638K Buy
+66,100
New +$429K ﹤0.01% 4743
2014
Q2 		– Sell
-200
Closed -$4K – 8046
2014
Q1 		$4K Sell
200
-140
-41% -$2.6K ﹤0.01% 7402
2013
Q4 		$7K Sell
340
-1,520
-82% -$22.2K ﹤0.01% 7391
2013
Q3 		$22K Buy
1,860
+570
+44% +$7.17K ﹤0.01% 6844
2013
Q2 		$14K Buy
+1,290
New +$27.2K ﹤0.01% 7070

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's DVAX Position: Q1 2026 in Review

Bank of America sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,057,175 shares — an estimated $16.3M sold.

Bank of America first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $42.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Bank of America reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,057,175 Dynavax Technologies shares in Q1 2026, an estimated $16.3M.
  • Bank of America first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Bank of America's Dynavax Technologies position peaked at $42.6M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.